We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$3.3M
Cap. Flow
-$3.52M
Cap. Flow %
-2%
Top 10 Hldgs %
34.97%
Holding
113
New
8
Increased
24
Reduced
32
Closed
7

Top Buys

Rank Stock Value
1
SRXH
SRX Global
SRXH
+$1.26M
2
ACHV icon
Achieve Life Sciences
ACHV
+$1.25M
3
BIOL
Biolase, Inc.
BIOL
+$1.09M
4
VVOS icon
Vivos Therapeutics
VVOS
+$1.06M
5
ASPU
ASPEN GROUP, INC.
ASPU
+$1M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$4.36M
2
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$1.92M
3
SHSP
SharpSpring, Inc.
SHSP
+$1.79M
4
SONM icon
DNA X Inc
SONM
+$1.49M
5
INTZ
INTRUSION INC NEW
INTZ
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 61.83%
2 Technology 15.72%
3 Communication Services 6.71%
4 Industrials 4.61%
5 Consumer Staples 4.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIEN icon
51
Ciena
CIEN
$53.4B
$1.04M 0.59%
18,250
– –
VZ icon
52
Verizon
VZ
$195B
$993K 0.56%
17,725
– –
QUMU
53
DELISTED
Qumu Corp.
QUMU
$980K 0.56%
340,400
-10,910
-3% -$53.6K
BLFS icon
54
BioLife Solutions
BLFS
$1.53B
$979K 0.56%
22,000
-500
-2% -$17.6K
MRK icon
55
Merck
MRK
$322B
$955K 0.54%
12,275
-589
-5% -$43.8K
TCMD icon
56
Tactile Systems Technology
TCMD
$635M
$925K 0.52%
17,792
– –
IFF icon
57
International Flavors & Fragrances
IFF
$20.2B
$816K 0.46%
5,460
– –
VVOS icon
58
Vivos Therapeutics
VVOS
$5.7M
$804K 0.46%
+6,500
New +$1.06M
MGNI icon
59
Magnite
MGNI
$2.76B
$796K 0.45%
23,525
– –
CEMI
60
DELISTED
Chembio diagnostics, Inc.
CEMI
$796K 0.45%
267,980
-21,700
-7% -$75.6K
AMD icon
61
Advanced Micro Devices
AMD
$776B
$794K 0.45%
8,450
– –
CYRX icon
62
CryoPort
CYRX
$761M
$726K 0.41%
11,500
-500
-4% -$28.1K
AAPL icon
63
Apple
AAPL
$4.54T
$678K 0.38%
4,950
– –
ITMR
64
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$635K 0.36%
26,950
– –
IIN
65
DELISTED
IntriCon Corporation
IIN
$633K 0.36%
28,150
-1,500
-5% -$34.8K
DCI icon
66
Donaldson
DCI
$10.9B
$608K 0.35%
9,567
– –
LFVN icon
67
LifeVantage
LFVN
$81.1M
$585K 0.33%
79,613
– –
MIRO
68
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$583K 0.33%
+50,000
New +$644K
PRFT
69
DELISTED
Perficient Inc
PRFT
$571K 0.32%
7,100
– –
NXPI icon
70
NXP Semiconductors
NXPI
$57.8B
$525K 0.3%
2,550
– –
PLUS icon
71
ePlus
PLUS
$2.42B
$520K 0.3%
12,000
– –
PRTK
72
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$520K 0.3%
76,200
+350
+0.5% +$2.83K
USB icon
73
US Bancorp
USB
$98.2B
$508K 0.29%
8,917
– –
CFMS
74
DELISTED
Conformis, Inc. Common Stock
CFMS
$506K 0.29%
17,600
-400
-2% -$9.45K
FAST icon
75
Fastenal
FAST
$54.7B
$499K 0.28%
19,200
– –
1 2
3
4 5

Similar funds

SVP
Strategic Value Partners Greenwich, Connecticut $133M AUM
PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
SFG
Synergy Financial Group San Ramon, California $133M AUM 22.16% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM
BAM
Brickwood Asset Management London, United Kingdom $133M AUM 10.27% 1-Year Est. Return

Perkins Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Perkins Capital Management held 113 positions worth $176M, up 1.9% from $173M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Perkins Capital Management's Q2 2021 filing shows 8 new, 24 increased, 32 reduced and 7 closed positions. Its largest new stake was SRX Global: 153 shares worth $1.29M. The largest sale was Vericel Corp, an estimated $4.36M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 63% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q2 2021 buy was SRX Global: 153 shares worth $1.29M.
  • Perkins Capital Management added most to Achieve Life Sciences in Q2 2021, an estimated $1.25M increase.
  • Perkins Capital Management's biggest Q2 2021 reduction was Vericel Corp, cutting an estimated $4.36M.
  • Perkins Capital Management fully exited Biora Therapeutics, Inc. Common Stock in Q2 2021, selling an estimated $1.92M.
  • Perkins Capital Management's ten largest holdings make up 35% of its $176M portfolio in Q2 2021.
  • Perkins Capital Management opened 8 new positions and closed 7 in Q2 2021.
  • Perkins Capital Management's portfolio value rose 1.9% quarter-over-quarter to $176M.

Based on Perkins Capital Management's 13F filing for Q2 2021, filed 28 Jul 2021.